Skip to main content

Table 3 Comparison of AKI in patients with HIV to patients without HIV or in whom HIV status was unknown

From: Incidence, aetiology and outcome of community-acquired acute kidney injury in medical admissions in Malawi

  No HIV or HIV unknown (n = 63) HIV (n = 90) P value
Demographics
 Age (median; IQR) 53 (35–71) 38 (32–46) 0 · 0004
Male sex 35 (55 · 6%) 57 (63 · 3%) 0 · 334
Primary cause of AKI
 Sepsis and hypoperfusion 51 (80 · 1%) 82 (91 · 1%) 0 · 058a
 Toxin 1 (1 · 6%) 4 (4 · 4%)
 Obstruction 6 (9 · 5%) 1 (1 · 1%)
 Parenchymal Kidney disease 2 (3 · 2%) 2 (2 · 2%)
 Unclear 3 (4 · 8%) 1 (1 · 1%)
AKI Severity
 AKI Stage 3 39 (61 · 9%) 54 (60 · 0%) 0 · 81
Outcomes
 In-hospital mortality 22 (37 · 9%) 42 (48 · 4%) 0 · 20
 Length of stay in days (median; IQR) 7 · 5 (4–13) 7 · 5 (5–11) 0 · 74
 Renal recovery (any) 27 (49 · 1%) 41 (49 · 4%) 0 · 97
 Persistent kidney injury at dischargeb 19 (70 · 4%) 24 (58 · 4%) 0 · 32
  1. AKI acute kidney injury, HIV human immunodeficiency virus
  2. aChi2 test assessing the association of the aetiological category of AKI between groups
  3. bexpressed as a proportion of those with any renal recovery